DC

Diamond Capital Management

North America, Wisconsin, United States, Pewaukee

Description

Diamond Capital Management is dedicated to offering clients well managed alternative investment products that offer consistent returns.

Investor Profile

Diamond Capital Management has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Life Science
  • Medical
  • Neuroscience
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Diamond Capital Management frequently co-invest with?

University of North Carolina at Chapel Hill
North America, North Carolina, United States, Chapel Hill
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 1
Lurie Investment Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Walden International
North America, California, United States, San Francisco
Co-Investments: 1
Global Life Science Ventures
Europe, Bayern, Germany, München
Co-Investments: 1
TIAA
North America, New York, United States, New York
Co-Investments: 1
Apjohn ventures
North America, Michigan, United States, Kalamazoo
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Diamond Capital Management?

CytoPherx

Ann Arbor, Michigan, United States

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Health CareLife ScienceMedical Device
Series BJun 17, 2010
Amount Raised: $11,700,000
TransMolecular

Birmingham, Alabama, United States

TransMolecular Inc a Birmingham, Ala.-based biotech company focused on the treatment of cancer and pain.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 1, 2004
Amount Raised: $33,200,000
NeurogesX

San Carlos, California, United States

NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.

BiotechnologyMedicalMedical DeviceNeuroscience
Series CFeb 24, 2004
Amount Raised: $35,000,000